Article ID Journal Published Year Pages File Type
9012941 Life Sciences 2005 5 Pages PDF
Abstract
The population studied consisted of 147 Japanese and 388 Israeli donors (100 Ashkenazi Jews, 99 Yemenite Jews, 100 Moroccan Jews and 89 Libyan Jews). The CYP2C9*2 [Arg144Cys (416 C > T), exon 3] and CYP2C9*3 [Ile359Leu (1061 A > C), exon 7] genotypes were determined using an OligoArrayR. The accuracy of genotyping by the OligoArrayR was verified by the fluorescent dye-terminator cycle sequencing method. A Hardy-Weinberg test indicated equilibrium (χ2 < 3.84 is Hardy-Weinberg) in all populations. The CYP2C9*2 genotype (CC / CT + TT) was absent in Japanese (1 / 0) (OR 0.02), and its frequency was significant in Libyan Jews (0.697 / 0.303) (OR 2.13; 95% CI 1.07-4.24) compared with Ashkenazi Jews (0.83 / 0.17), Yemenite Jews (0.899 / 0.101), and Moroccan Jews (0.81 / 0.19). The frequencies of CYP2C9*3 genotype (AA / AC + CC) was significantly lower in Japanese (0.986 / 0.014) (OR 0.08), and was higher in Libyan Jews (0.652 / 0.348) (OR 3.03; 95% CI 1.5-6.1) and Moroccan Jews (0.77 / 0.23) (OR 1.69; 95% CI 0.62-3.48) compared with those in Ashkenazi Jews (0.85 / 0.15) and Yemenite Jews (0.849 / 0.151). Thus, the CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) variants were rare in the Japanese population, and showed different frequencies in the four Jewish ethnic groups examined.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , ,